Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 15,043 | 14,400 | 15,121 | 18,822 | 22,596 |
| Operating Income | -15,043 | -14,400 | -15,121 | -18,822 | -22,596 |
| Other Income | 3,250 | 3,295 | 3,279 | 3,033 | 2,659 |
| Pre-tax Income | -11,793 | -11,105 | -11,842 | -15,789 | -19,937 |
| Net Income Continuous | -11,793 | -11,105 | -11,842 | -15,789 | -19,937 |
| Net Income | $-11,793 | $-11,105 | $-11,842 | $-15,789 | $-19,937 |
| EPS Basic Total Ops | -0.21 | -0.20 | -0.20 | -0.28 | -0.36 |
| EPS Basic Continuous Ops | -0.21 | -0.20 | -0.21 | -0.28 | -0.36 |
| EPS Diluted Total Ops | -0.21 | -0.20 | -0.20 | -0.28 | -0.36 |
| EPS Diluted Continuous Ops | -0.21 | -0.20 | -0.21 | -0.28 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.20 | -0.21 | N/A | N/A |
| EBITDA(a) | $-16,465 | $-15,988 | $-16,819 | $-20,394 | $-23,860 |